603301 Stock Overview
Engages in the research and development, production, and sale of medical care and protective equipment in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Zhende Medical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.66 |
| 52 Week High | CN¥26.54 |
| 52 Week Low | CN¥15.68 |
| Beta | 0.38 |
| 1 Month Change | -3.00% |
| 3 Month Change | 13.76% |
| 1 Year Change | -6.60% |
| 3 Year Change | -57.61% |
| 5 Year Change | 50.78% |
| Change since IPO | 55.62% |
Recent News & Updates
Zhende Medical's (SHSE:603301) Weak Earnings May Only Reveal A Part Of The Whole Picture
Nov 05
Cautious Investors Not Rewarding Zhende Medical Co., Ltd.'s (SHSE:603301) Performance Completely
Oct 15Shareholder Returns
| 603301 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -3.7% | -2.8% | -1.2% |
| 1Y | -6.6% | -9.2% | 11.8% |
Return vs Industry: 603301 exceeded the CN Medical Equipment industry which returned -9.2% over the past year.
Return vs Market: 603301 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 603301 volatility | |
|---|---|
| 603301 Average Weekly Movement | 5.4% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603301 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603301's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 6,717 | Jianguo Lu | www.zhende.com |
Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China. It offers stoma and modern wound care products, surgical infection control products, sensory control protection products, infection control protection products, basic wound care products, and pressure therapy and immobilization products, as well as medical-grade personal care and home health care products. The company sells its products approximately in 70 countries and regions in Europe, North America, Asia, South America, Africa, and Oceania.
Zhende Medical Co., Ltd. Fundamentals Summary
| 603301 fundamental statistics | |
|---|---|
| Market cap | CN¥6.03b |
| Earnings (TTM) | CN¥205.34m |
| Revenue (TTM) | CN¥4.04b |
29.4x
P/E Ratio1.5x
P/S RatioIs 603301 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603301 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.04b |
| Cost of Revenue | CN¥2.78b |
| Gross Profit | CN¥1.26b |
| Other Expenses | CN¥1.06b |
| Earnings | CN¥205.34m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.77 |
| Gross Margin | 31.26% |
| Net Profit Margin | 5.08% |
| Debt/Equity Ratio | 16.1% |
How did 603301 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 05:00 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhende Medical Co., Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wei Sun | China Merchants Securities Co. Ltd. |
| Shuo Song | Citic Securities Co., Ltd. |
| Jiabo Zhang | Guosen Securities Co., Ltd. |